Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
Clinical trial NCT03051672 · TERMINATED
Trial details
- NCT number
- NCT03051672
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2018-09-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.